Small Cap Feast

21th February 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 


Delistings:
Sopheon (SPE.L) has left AIM



Whats baking in the oven?

Potential Initial Public Offerings:

12 January: The London Tunnels PLC announces its intention to seek Admission to the Standard Segment of the Official List and to trading on the Main Market of the LSE. The Company plans to restore, adaptively reuse and bring back to life the Kingsway Exchange Tunnels in Central London, originally built in the early 1940’s, and designed to shelter people during the London Blitz. The Company has successfully raised approximately £10m from investors and aims to admit its Ordinary Shares at a price of £2.00 per share to the Main Market. The Company is expected to have a market capitalisation of approximately £123m on Admission. Delayed: Expected Admission was before the end of January 2024.


Reverse Takeovers:


Change of Market:


Banquet Buffet

Arcontech 93p £12.4m (ARC.L)
The provider of products and services for real-time financial market data processing and trading reports its unaudited results for the six months ended 31 December 2023 (H1 FY23). Revenue increased by 6.8% to £1.45m (H1 FY22: £1.36m). Profit before tax increased by 44.7% to £539k (H1 FY22: £372k) reflecting the contribution from higher revenues and higher interest earned on cash deposits. Net cash was £5.7m at 31 December 2023, down 2.9% (H1 FY22: £5.9m) after a record dividend payment of £468,048 paid on 3 November 2023. Revenue for the full year remains in line with market expectations, and profit before tax for the year to 30 June 2024 is expected to be slightly ahead of market expectations.

Corero Network Security 8.25p £42.0m (CNS.L)
The provider of distributed denial of service (DDoS) protection solutions announces an important strategic partnership with TechEnabler, an established Brazilian network solutions distributor. The partnership is underpinned by a revenue-sharing model and will enable Corero to expand its Latin American (LATAM) footprint. Leveraging TechEnabler's extensive network and technical expertise, the partnership will enable Corero to deploy its flagship SmartWall ONE platform to new customers.

Dewhurst Group 900p £58.2m (DWHT.L)
The global manufacturer and supplier of quality components to the lift, transport and keypad industries announces that it will acquire the remaining 25% of its investee P&R Liftcars for a consideration of A$2.9m in cash. P&R Liftcars, based in Australia, is a lift car interior manufacturer. For the year ended 30 September 2023, P&R Liftcars reported profit after tax of A$163k and net assets of A$5.7m, a figure materially lower than in recent years. This is due to fewer capital projects being released during the pandemic which impacted P&R in its 2023 financial year. As at 31 January 2024, P&R Liftcars' contracted and forward orders comprised A$4.0m.

Feedback 62.5p £8.3m (FDBK.L)
The clinical infrastructure specialist announces its audited results for the six months to 30 November 2023 (H1 FY24). Revenue was £437k (H1 FY23: £576k), 24% lower primarily due to the timing of revenue recognition of the QVH/Sussex ICS pilot contract during the previous period and legacy product contracts reaching end of term. EBITDA loss increased to £1,675k (H1 FY23: £1,226k) reflecting lower revenue and higher operating costs. Cash as at 30 November 2023 was £5,372k (31 May 2023: £7,318k). Meanwhile, Feedback also announces that radiology specialist Medical Imaging Partnership (MIP) has agreed to pilot Bleepa-CareLocker, in order to deliver multiple clinical pathways to its customers in the UK private healthcare sector.

H&T Group 380.5p £167.4m (HAT.L)
The UK's largest pawnbroker and a leading retailer of high quality new and pre-owned jewellery and watches announces the acquisition of certain assets of Maxcroft Securities Ltd for a cash consideration of £11.3m. Maxcroft is a longstanding and successful pawnbroking business based in Essex. H&T Group also announces £25m of additional financing from Pricoa Private Capital, the private capital arm of PGIM, Inc., the global investment management business of Prudential Financial, Inc. The additional funding will enable future growth in the pledge book and investment in the store portfolio.

Power Metal Resources 0.9p £19.4m (POW.L)
The exploration Company seeking large-scale metal discoveries across its global project portfolio announces its consolidated audited results for the year ended 30 September 2023 (FY23). Revenue was £78k, up 110% from £37k in FY22, the loss before tax was £1.3m (FY22: £2.9m in losses) and the cash balance was £1.1m (FY22: £1.6m). Power Metal currently has a 100% interest in eighteen uranium properties in the Athabasca Region of Saskatchewan, Canada. This is the largest ground footprint in the Athabasca Region held by a UK listed company. A number of such opportunities are currently in the pipeline and the Board remains confident that with ongoing operations.

Shield Therapeutics 2.95p £23.1m (STX.L)
The commercial-stage pharmaceutical Company that delivers Accrufer/Feraccru (ferric maltol) provides an unaudited trading update for the year ended 31 December 2023. FY23 revenue and other income totalled $17.5m, a 2.8x increase over FY22 and the cash was $13.9m as of 31 December 2023. Total 2023 Prescriptions totalled c.77k, a 3.1x increase over FY22. Shield has recently identified that the projection methodology used by its third-party data provider resulted in an overstatement of total prescriptions in 2023. This development was partly responsible for the Group not achieving previously indicated guidance of total prescriptions in FY23 of 100k to 130k. With these revised prescription numbers, Shield is revisiting its previously communicated guidance on its final results.

Software Circle 15p £58.5m (SFT.L)
The serial acquirer of great vertical market software businesses announces that it has acquired the entire issued share capital of ARC Technology Limited, for a total consideration of up to £2.0m will be satisfied in cash and is structured on a debt free/cash free basis. ARC Technology Limited, based in Byfleet, Surrey, is a provider of software solutions for the management of practice-based learning to higher education institutions across the UK and the Republic of Ireland. The unaudited financial statements for ARC for the year ended 31 July 2023 reported revenue of £1.1m, EBIT of £0.34m and closing net assets of £0.94m.

TomCo Energy 0.05p £1.6m (TOM.L)
The US operating oil development Company focused on using innovative technology to unlock unconventional hydrocarbon resources announces that it has raised gross proceeds of £300k at a discount of approximately 47.1% to the mid-market closing price on 20 February 2024, The proceeds will be used to fund the Company's anticipated expenditure as it seeks to progress its plans for 100%-owned subsidiary, Greenfield Energy LLC, in relation to the Tar Sands Holdings II LLC site located in the Uinta Basin, Utah.

Windward 122.5p £104.9m (WNWD.L)
The leading Maritime AI Company is pleased to be able to publicly announce its contract with INTERPOL that was entered into in H2 2023. Windward has announced a partnership with INTERPOL, The International Criminal Police Organization, to assist in their mission of facilitating a secure maritime environment. Windward's platform will enhance INTERPOL's capacity to detect and disrupt illegal maritime activities, including smuggling, piracy, IUU, human trafficking, and the transportation of illegal goods.

.

21 February 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram